AMXOF(AMXOF)
AMXOF
No analyst ratings available
No analyst price targets available for AMXOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $56.31B | $59.56B | $62.20B | $64.25B | $62.10B |
| Low | $54.32B | $56.60B | $59.54B | $61.51B | $59.45B |
| High | $57.22B | $60.41B | $63.14B | $65.23B | $63.05B |
| EBITDA Avg | $223.77B | $199.18B | $180.19B | $165.77B | $149.87B |
| Low | $223.37B | $198.72B | $179.66B | $165.13B | $149.39B |
| High | $223.91B | $199.35B | $180.38B | $165.99B | $150.04B |
| EBIT Avg | $75.37B | $76.49B | $77.89B | $79.64B | $76.83B |
| Low | $74.97B | $76.03B | $77.35B | $79.01B | $76.35B |
| High | $75.51B | $76.65B | $78.08B | $79.86B | $77.00B |
| Net Income Avg | $5.63B | $6.52B | $7.62B | $9.00B | $6.78B |
| Low | $5.32B | $6.16B | $7.20B | $8.50B | $6.41B |
| High | $5.74B | $6.65B | $7.77B | $9.18B | $6.92B |
| EPS Avg | $0.09 | $0.11 | $0.13 | $0.15 | $0.11 |
| Low | $0.09 | $0.10 | $0.12 | $0.14 | $0.11 |
| High | $0.10 | $0.11 | $0.13 | $0.15 | $0.11 |
| Analysts (Rev / EPS) | 18 / 1 | 16 / 1 | 13 / 1 | 14 / 1 | 14 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $14.22B | $14.78B | $14.53B | $14.90B | $14.91B | $15.56B | $15.29B | $15.69B |
| Low | $14.02B | $14.62B | $14.35B | $14.71B | $14.72B | $15.36B | $15.10B | $15.49B |
| High | $14.37B | $14.91B | $14.67B | $15.04B | $15.05B | $15.70B | $15.44B | $15.84B |
| EBITDA Avg | $62.07B | $60.27B | $58.93B | $57.43B | $56.17B | $54.96B | $53.58B | $52.41B |
| Low | $62.04B | $60.24B | $58.90B | $57.40B | $56.13B | $54.91B | $53.53B | $52.36B |
| High | $62.09B | $60.29B | $58.96B | $57.46B | $56.20B | $54.99B | $53.62B | $52.45B |
| EBIT Avg | $20.00B | $20.06B | $20.49B | $20.66B | $20.99B | $21.28B | $21.33B | $21.51B |
| Low | $19.98B | $20.03B | $20.46B | $20.63B | $20.95B | $21.24B | $21.28B | $21.46B |
| High | $20.02B | $20.08B | $20.52B | $20.69B | $21.02B | $21.32B | $21.37B | $21.55B |
| Net Income Avg | $1.21B | $1.25B | $1.59B | $1.73B | $1.98B | $2.22B | $2.25B | $2.40B |
| Low | $1.19B | $1.23B | $1.57B | $1.70B | $1.95B | $2.18B | $2.22B | $2.36B |
| High | $1.22B | $1.26B | $1.61B | $1.75B | $2.01B | $2.24B | $2.28B | $2.43B |
| EPS Avg | $0.02 | $0.02 | $0.03 | $0.03 | $0.03 | $0.04 | $0.04 | $0.04 |
| Low | $0.02 | $0.02 | $0.03 | $0.03 | $0.03 | $0.04 | $0.04 | $0.04 |
| High | $0.02 | $0.02 | $0.03 | $0.03 | $0.03 | $0.04 | $0.04 | $0.04 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 |